Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 5-chloro-2-[[3-(trifluoromethyl)phenyl]amino]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

55279-15-7

Post Buying Request

55279-15-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55279-15-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 55279-15-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,2,7 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 55279-15:
(7*5)+(6*5)+(5*2)+(4*7)+(3*9)+(2*1)+(1*5)=137
137 % 10 = 7
So 55279-15-7 is a valid CAS Registry Number.

55279-15-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[[3-(trifluoromethyl)phenyl]amino]-5-chlorobenzoic acid

1.2 Other means of identification

Product number -
Other names 5-chloroflufenamic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55279-15-7 SDS

55279-15-7Downstream Products

55279-15-7Relevant academic research and scientific papers

Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification

Van Antwerpen, Pierre,Prevost, Martine,Zouaoui-Boudjeltia, Karim,Babar, Sajida,Legssyer,Moreau, Patrick,Moguilevsky, Nicole,Vanhaeverbeek, Michel,Ducobu, Jean,Neve, Jean,Dufrasne, Francois

, p. 1702 - 1720 (2008/09/20)

The development of myeloperoxidase (MPO) inhibitors has been conducted using flufenamic acid as a lead compound. Computational docking of the drug and its analogs in the MPO active site was first attempted. Several molecules were then synthesized and assessed using three procedures for the measurement of their inhibiting activity: (i) the taurine assay, (ii) the accumulation of compound II, and (iii) the LDL oxidation by ELISA. Most of the synthesized molecules had an activity in the same range as flufenamic acid but none of them were able to inhibit the MPO-dependent LDL oxidation. The experiments however gave some useful indications for a rational conception of MPO inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 55279-15-7